CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net income	$ 24,071	$ 23,009
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	500	300
Depreciation and amortization	756	763
Net accretion of securities premiums and discounts	(1,025)	(276)
Stock based compensation expense	3,518	2,042
Increase in cash surrender value of BOLI	(638)	(603)
Decrease in deferred income taxes, net	3,300	6,959
Net changes in:
Other assets	10,124	3,935
Other liabilities	110	3,421
Net cash provided by operating activities	40,716	39,550
Cash flows from investing activities:
Net decrease in loans and leases held for investment	32,158	94,058
Purchase of available-for-sale securities	0	(33,186)
Purchase of held-to-maturity securities	(1,050)	(1,945)
Proceeds from sales, maturities, calls and pay downs of available-for-sale securities	40,499	9,274
Proceeds from maturities, calls and pay downs of held-to-maturity securities	11,430	11,489
Purchase of premises and equipment	(9,535)	(673)
Purchase of other investments	(3,135)	(2,047)
Proceeds from sale of assets	0	53
Net cash provided by investing activities	70,367	77,023
Cash flows from financing activities:
Net increase in deposits	138,447	278,829
Cash dividends paid	(3,665)	0
Restricted stock vesting distribution	(6,303)	0
Cash used in share repurchase program	0	(711)
Purchase of treasury stock	(202)	0
Net cash provided by financing activities	128,277	278,118
Net change in cash and cash equivalents	239,360	394,691
Cash and cash equivalents, beginning of period	144,864	212,563
Cash and cash equivalents, end of period	384,224	607,254
Supplemental disclosures of cash flow information:
Cash paid for interest	16,121	15,109
Income taxes paid	0	1,234
Supplemental disclosures of non-cash transactions:
Accrued cash dividend on restricted stock	(30)	0
Net change in unrealized gains/(losses) on securities available-for-sale	$ 9,731	$ (6,959)